通过HMGB1-TLR4依赖的微质炎症调解PAG神经NMDARs激活的吗啡诱导的过敏症
Jingjing Mo1, Zijing Lu2, Jialing Peng3
1Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Journal of psychiatric research
|June 23, 2023
概括
长期使用吗啡会通过在周水管灰细胞中的Toll-like受体4 (TLR4) 激活引起阿片类药物诱导的过敏症 (OIH). 这一途径涉及高流动性组盒1 (HMGB1) 和微质,导致神经元过激动性和OIH.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物诱导的过敏症 (OIH) 是一个重要的临床挑战,限制了吗啡的止痛效果.
- 导致OIH的精确机制,特别是Toll-like受体4 (TLR4) 和谷氨酸受体在周水道灰色 (PAG) 中的作用,仍然不完全理解.
研究的目的:
- 阐明在OIH期间PAG中TLR4和N-甲基-D-酸盐受体 (NMDARs) 激活之间的关联.
- 研究微质和特定分子通路在吗啡诱导的过敏症中的作用.
主要方法:
- 利用OIH的小鼠模型,观察微质激活,TLR4/p65NF-κB信号传递,以及PAG中的NMDAR亚单元酸化.
- 采用细胞培养 (BV2,N2A) 来研究高流动性组框1 (HMGB1) 的TLR4激活及其对NMDARs的下游影响.
- 使用TLR4抑制,淘汰和淘汰 (Lentivirus-GFP-TLR4shRNA) 进行干预,以评估它们对OIH的影响.
主要成果:
- 吗啡诱导微质激活,增加TLR4/p65NF-κB,以及PAG和BV2细胞中的炎症性细胞因子.
- 吗啡通过HMGB1,而不是MD2激活了TLR4,导致微质衍生炎症,在相邻神经元中化NMDAR子单元 (NR1,NR2B).
- 在PAG中TLR4淘汰赛逆转了这些分子变化,并显著缓解了OIH症状.
结论:
- 吗啡诱导的OIH涉及PAG微质中的TLR4激活,由HMGB1.1调解.
- 激活的微质细胞释放炎症因子,在神经元中酸化NMDARs,增加刺激性并导致OIH.
- 在PAG中准TLR4/NMDAR通路为管理OIH提供了一个有希望的治疗策略.
相关概念视频
Analgesia and Pain Management
668
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
668
Opioid Receptors: Overview
1.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.1K


